Session » Rheumatoid Arthritis – Diagnosis, Manifestations, and Outcomes Poster I: Comorbidities

Date: Sunday, October 21, 2018

Time: 9:00AM-11:00AM

Meeting: 2018 ACR/ARHP Annual Meeting

9:00AM-11:00AM: Abstract Number: 492

All Site Cancers and Lymphoma Incidence in US Veterans with Rheumatoid Arthritis 2001-2015

9:00AM-11:00AM: Abstract Number: 522

Analysis of Sequential Development of Pulmonary Lesions in Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 494

Arterial Wall Inflammation Declines after 6 Months of Anti-Inflammatory Therapy with Methotrexate and/or Adalimumab in Rheumatoid Arthritis Patients

9:00AM-11:00AM: Abstract Number: 533

Association between Inflammation and Changes in Kidney Function in Patients with Early Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 531

Association of Rheumatoid Arthritis and Other Autoinmune Diseases

9:00AM-11:00AM: Abstract Number: 485

Bone Loss in Different Sites over Time in Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 526

Bronchiectasis in RA Is a Crucial Risk Factor of Hospitalised Pneumonia Associated with Bdmards As Well As Interstitial Lung Disease

9:00AM-11:00AM: Abstract Number: 518

Cardiometabolic Risk Factors Impact on the Cardioprotective Effect of Apelin on Systolic and Diastolic Function, in Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 509

Cardiovascular Disease Risk Factors May Negatively Impact Rheumatoid Arthritis Disease Outcomes: Findings from the Ontario Best Practices Research Initiative

9:00AM-11:00AM: Abstract Number: 514

Cardiovascular Risk Management in Seropositive Rheumatoid Arthritis: What Can We Do Better?

9:00AM-11:00AM: Abstract Number: 490

Catastrophizing in Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 495

Characteristics of Metabolic Syndrome in Men and Women with Early Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 529

Chest Computed Tomography Abnormalities in Patients with Rheumatoid Arthritis By Serologic Status

9:00AM-11:00AM: Abstract Number: 506

Clinical and Sonographic Characteristics of Carotid Intima-Media Thickness in Rheumatoid Arthritis Patients

9:00AM-11:00AM: Abstract Number: 524

Clinical Course of Interstitial Lung Disease in Rheumatoid Arthritis Patients in Clinical Practice

9:00AM-11:00AM: Abstract Number: 487

Cognitive Impairment in Rheumatoid Arthritis Patients: A Case-Control Study

9:00AM-11:00AM: Abstract Number: 491

Cognitive Impairment Is Associated with Disease Activity in Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 483

Correlation between Disease Activity and Hip Score in Patients with Rheumatoid Arthritis after Total Hip Arthroplasty

9:00AM-11:00AM: Abstract Number: 540

Echocardiographic Abnormalities in Rheumatoid Arthritis Patients Compared to Age, Sex and Traditional Cardiovascular Risk Factors Matched Controls

9:00AM-11:00AM: Abstract Number: 507

Echocardiographic Markers of Right Ventricle Dysfunction in Hispanic Patients with Rheumatoid Arthritis: A Case-Control Study

9:00AM-11:00AM: Abstract Number: 517

Effects of Statin-Treatment on Coronary Plaques in Patients with Inflammatory Joint Diseases

9:00AM-11:00AM: Abstract Number: 520

Factors Associated with the Developement of Severe Respiratory Infections in Patients with Rheumatoid Arthritis Included in a Vaccination Program

9:00AM-11:00AM: Abstract Number: 496

Heart Failure Risk Among Patients with Rheumatoid Arthritis: Association with Anti-Rheumatic Drugs

9:00AM-11:00AM: Abstract Number: 515

How Knowledgeable Are Patients with Rheumatoid Arthritis about Cardiovascular Disease?

9:00AM-11:00AM: Abstract Number: 511

Identifying Vulnerable Plaque in Rheumatoid Arthritis Using Novel Microbubble Contrast-Enhanced Carotid Ultrasonography and Serum Biomarkers of Inflammation and Atherosclerosis

9:00AM-11:00AM: Abstract Number: 505

Impact of Biological Treatment on Left Ventricular Regional Dysfunction in Rheumatoid Arthritis Patients Determined with Global Circumferential and Longitudinal Strain Values Using Cardiac Magnetic Resonance Imaging

9:00AM-11:00AM: Abstract Number: 500

Impact of Inflammation and Biologic Treatments on Generation and Progression to Advanced Calcified Coronary Plaques in Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 502

Implications of Coronary Artery Calcium Score and Its Change over Time As Markers of Coronary Plaque Vulnerability and Patient Risk in Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 542

Incidence and Prevalence of Interstitial Lung Disease in the US Population and in Patients with RA By Anti-Citrullinated Protein Antibody Status

9:00AM-11:00AM: Abstract Number: 512

Incidence of First Cardiovascular Event in Spanish Patients with Chronic Inflammatory Rheumatic Diseases: Prospective Data from an Observational Multicentric Study

9:00AM-11:00AM: Abstract Number: 497

Increased Concentration of Large Very Low Density Lipoprotein Particles Associates with Progression of Carotid Atherosclerosis in Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 534

Increased Insulin Resistance and Impaired Beta-Cell Function in Patients with Rheumatoid Arthritis: The Role of Glucocorticoid Therapy?

9:00AM-11:00AM: Abstract Number: 537

Increased Risk of Incident Chronic Kidney Disease Among Patients with Rheumatoid Arthritis: A Systematic Review and Meta-Analysis of Cohort Studies

9:00AM-11:00AM: Abstract Number: 535

Is There Achilles Tendon Damage in Rheumatoid Arthritis Patients?

9:00AM-11:00AM: Abstract Number: 510

Lipid Profile and Cardiovascular Risk in Subjects at Risk for Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 527

Long-Term Follow up of Subclinical Interstitial Lung Disease in Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 499

Low Inflammatory Burden and Statin Exposure Inhibit Progression and Induce Regression of Early Coronary Plaques in Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 525

Low Interstitial Lung Disease Event Rate in Patients with Rheumatoid Arthritis: Pooled Post Hoc Analysis of Data from the Tofacitinib Clinical Development Program

9:00AM-11:00AM: Abstract Number: 513

Low Serum IGF1 Is Associated with Higher Cardiovascular Morbidity in the Middle-Aged Women with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 519

Marginal Structure Modeling of Association between Disease Activity and Hospitalized Infection Among Patients in a Rheumatoid Arthritis Registry

9:00AM-11:00AM: Abstract Number: 516

Microalbuminuria in Rheumatoid Arthritis: Investigating the Association with Diffuse Functional and Morphological Alterations of the Retinal Microvasculature, the Dermal Capillary Network and the Coronary Microcirculation

9:00AM-11:00AM: Abstract Number: 508

Non-Invasive Evaluation of Left Atrial Pressure in Hispanic Patients with Rheumatoid Arthritis: A Case-Control Study

9:00AM-11:00AM: Abstract Number: 501

Predictors of Change in Coronary Plaque Burden and Composition in Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 536

Prevalence and Relative Factors for Frailty in Patients with RA from a Prospective Observational Study

9:00AM-11:00AM: Abstract Number: 541

Prevalence of Sjögren’s Syndrome in Patients with RA Enrolled in a Large Observational US Registry

9:00AM-11:00AM: Abstract Number: 528

Progression in Interstitial Lung Disease – Comparison of Rheumatoid Arthritis with Idiopathic Pulmonary Fibrosis

9:00AM-11:00AM: Abstract Number: 530

RA-Voice: Evaluating Laryngeal Involvement in Rheumatoid Arthritis Patients

9:00AM-11:00AM: Abstract Number: 532

Relationship between Insulin Sensitivity and Beta Cell Secretion in Non-Diabetic Rheumatoid Arthritis Subjects

9:00AM-11:00AM: Abstract Number: 484

Rheumatoid Arthritis Patients Have Lower Preoperative Expectations but Greater Clinical Improvement after Total Knee Arthroplasty Compared to Osteoarthritis Patients

9:00AM-11:00AM: Abstract Number: 489

Self-Reported Depression in Patients with Rheumatoid Arthritis Is Undertreated and Associated with Poorer Clinical Status and Lower Rates of Remission in Routine Care

9:00AM-11:00AM: Abstract Number: 486

The Electrophysiologic and Sonographic Evaluation of Peripheral Nerves in Rheumatoid Arthritis Patients

9:00AM-11:00AM: Abstract Number: 521

The Lung in an English Cohort of Rheumatoid Arthritis Patients – an Overview of Different Types of Involvement and Treatment

9:00AM-11:00AM: Abstract Number: 523

The Prevalence and Clinical Characteristics of Rheumatoid Arthritis with Interstitial Lung Disease in the San Joaquin Valley of Central California

9:00AM-11:00AM: Abstract Number: 539

Thyroid Function in Early Versus Established Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 498

Trends in the Incidence of Cardiovascular Diseases in Patients with Rheumatoid Arthritis in Spain: A National Observational Cohort Study of Hospital Discharges

9:00AM-11:00AM: Abstract Number: 493

Trends in the Incidence of SOLID Tumors in Patients with Rheumatoid Arthritis in Spain. a National Observational Cohort Study

9:00AM-11:00AM: Abstract Number: 538

Type 1 Diabetes in RA: Comparison with Type 2 and Its Association with RA Severity and Treatment

9:00AM-11:00AM: Abstract Number: 504

Views of Primary Care Physicians and Rheumatologists Regarding Screening and Management of Hyperlipidemia Among Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 503

Waist Circumference Based Abdominal Obesity Versus Body Mass Index in Rheumatoid Arthritis: Influence on the Risk of Diabetes and Cardiovascular Disease

« View all sessions from this meeting

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].